A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women



Status:Archived
Conditions:Osteoporosis, Postmenopausal Syndrome
Therapuetic Areas:Endocrinology, Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2010
End Date:March 2011

Use our guide to learn which trials are right for you!


This study is a Phase 1, multi-center, 2-part, subject- and investigator-blind, randomized,
placebo-controlled, multiple dose study of transdermal teriparatide (80-µg dose) in healthy
postmenopausal women. Part A will examine the cumulative irritation and adherence of the
transdermal patch, and Part B will examine skin sensitization and adherence. Two separate
groups of subjects will be enrolled for Part A and Part B of the study. All screening
procedures will take place up to 28 days prior to enrollment.



We found this trial at
2
sites
?
mi
from
Miami, FL
Click here to add this to my saved trials
1 Medical Center Drive
Morgantown, West Virginia 26506
304-598-4800
West Virginia University Hospitals Inc. WVU Healthcare is two corporations, University Health Associates and WVU...
?
mi
from
Morgantown, WV
Click here to add this to my saved trials